(Press-News.org) Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed an innovative drug-delivery system in which tiny particles called nanodiamonds are used to carry chemotherapy drugs directly into brain tumors. The new method was found to result in greater cancer-killing efficiency and fewer harmful side effects than existing treatments.
The research, published in the advance online issue of the peer-reviewed journal Nanomedicine: Nanotechnology, Biology and Medicine, was a collaboration between Dean Ho of the UCLA School of Dentistry and colleagues from the Lurie Children's Hospital of Chicago and Northwestern University's Feinberg School of Medicine. Ho co-directs UCLA Dentistry's Weintraub Center for Reconstructive Biotechnology and is a professor in the division of oral biology and medicine, the division of advanced prosthodontics, and the department of bioengineering.
Glioblastoma is the most common and lethal type of brain tumor. Despite treatment with surgery, radiation and chemotherapy, the median survival time for glioblastoma patients is less than one-and-a-half years. The tumors are notoriously difficult to treat, in part because chemotherapy drugs injected alone often are unable to penetrate the system of protective blood vessels that surround the brain, known as the blood–brain barrier. And those drugs that do cross the barrier do not stay concentrated in the tumor tissue long enough to be effective.
The drug doxorubicin, a common chemotherapy agent, has shown promise in a broad range of cancers, and it has served as model drug for the treatment brain tumors when injected directly into the tumor. Ho's team originally developed a strategy for strongly attaching doxorubicin molecules to nanodiamond surfaces, creating a combined substance called ND–DOX.
Nanodiamonds are carbon-based particles roughly 4 to 5 nanometers in diamter that can carry a broad range of drug compounds. And while tumor-cell proteins are able to eject most anticancer drugs that are injected into the cell before those drugs have time to work, they can't get rid of the nanodiamonds. Thus, drug–nanodiamond combinations remain in the cells much longer without affecting the tissue surrounding the tumor.
Ho and his colleagues hypothesized that glioblastoma might be efficiently treated with a nanodiamond-modified drug by using a direct-injection technique known as convection-enhanced delivery, or CED. They used this method to inject ND–DOX directly into brain tumors in rodent models.
The researchers found that ND–DOX levels in the tumors were retained for a duration far beyond that of doxorubicin alone, showing that doxorubicin was taken into the tumor and remained their longer when attached to nanodiamonds. In addition, ND–DOX was also found to increase apoptosis — programmed cancer-cell death — and to decrease cell viability in glioma (brain cancer) cell lines.
The results also demonstrated for the first time that the ND–DOX delivery limited the amount of doxorubicin that was distributed outside the tumor. This reduced toxic side effects and kept more of the drug in the tumor for longer, increasing the drug's tumor-killing efficiency without affecting the surrounding tissue. Survival time increased significantly in the rats treated with ND–DOX, compared with those given only unmodified doxorubicin.
Nanodiamonds have many facets, almost like the surface of a soccer ball, and can bind to doxorubicin very strongly and quickly, Ho noted. Further research will expand the list of brain-cancer chemotherapy drugs that can be attached to the nanodiamond surfaces to improve treatment and reduce side effects.
For a nanoparticle to have translational significance, it has to have as many benefits engineered into one system as simply as possible.
"Nanomaterials are promising vehicles for treating different types of cancer," Ho said. "We're looking for the drugs and situations where nanotechnology actually helps chemotherapy function better, making it easier on the patient and harder on the cancer."
This study showed that convection-enhanced delivery of ND–DOX offers a powerful treatment delivery system against these very difficult and deadly brain tumors, Ho said.
He noted that this large-scale project has been successful thanks to the multidisciplinary and proactive interactions between his team of bioengineers and their outstanding clinical collaborators from Northwestern University and Lurie Children's Hospital.
###
This research was supported by a National Science Foundation CAREER Award, the Center for Scalable and Integrated NanoManufacturing, a V Foundation for Cancer Research Scholars Award, a Wallace H. Coulter Foundation Translational Research Award, a Society for Laboratory Automation and Screening Endowed Fellowship, Beckman Coulter, the European Commission funding program, and the National Cancer Institute.
UCLA's Jonsson Comprehensive Cancer Center has more than 240 researchers and clinicians engaged in disease research, prevention, detection, control, treatment and education. One of the nation's largest comprehensive cancer centers, the Jonsson center is dedicated to promoting research and translating basic science into leading-edge clinical studies. In July 2013, the Jonsson Cancer Center was named among the top 12 cancer centers nationwide by U.S. News & World Report, a ranking it has held for 14 consecutive years.
For more news, visit the UCLA Newsroom and follow us on Twitter.
New system uses nanodiamonds to deliver chemotherapy drugs directly to brain tumors
2013-09-12
ELSE PRESS RELEASES FROM THIS DATE:
'Incidental findings' rare but significant events in pediatric CT scans
2013-09-12
(SACRAMENTO, Calif.) — The largest study of computed tomographic (CT) scans taken in emergency departments across the country for children with head injuries describes the prevalence of "incidental findings" — results that were not expected from the injury — and categorizes them by urgency.
The article, titled "Incidental findings in children with blunt head trauma evaluated with cranial CT scans," was published in the August issue of Pediatrics, and provides a context for doctors in emergency departments who encounter these situations.
"Incidental findings are a ...
Brain atrophy linked with cognitive decline in diabetes
2013-09-12
New research has shown that cognitive decline in people with Type 2 Diabetes is likely due to brain atrophy, or shrinkage, that resembles patterns seen in the early stages of Alzheimer's disease.
Dr Chris Moran and Associate Professor Velandai Srikanth of Monash University led the first large-scale study to compare brain scans and cognitive function between people with and without Type 2 Diabetes Mellitus (T2DM). They found that brain atrophy, rather than cerebrovascular lesions, was likely the primary reason for cognitive impairment associated with T2DM.
The World ...
Terahertz time-domain spectroscopy for oil and gas detection
2013-09-12
A greater understanding of the evolutionary stage of kerogen for hydrocarbon generation would play a role in easing the world's current energy problem. Professor ZHAO Kun and his group from the Key Laboratory of Oil and Gas Terahertz Spectrum and Photoelectric Detection (CPCIF, China University of Petroleum, Beijing) set out to tackle this problem. After five years of innovative research, they have developed terahertz time-domain spectroscopy (THz-TDS) as an effective method to detect the generation of oil and gas from kerogen. Their work, entitled "Applying terahertz time-domain ...
Cilantro, that favorite salsa ingredient, purifies drinking water
2013-09-12
Contact: Michael Bernstein
m_bernstein@acs.org
317-262-5907 (Indianapolis Press Center, Sept. 6-11)
202-872-6042
Michael Woods
m_woods@acs.org
317-262-5907 (Indianapolis Press Center, Sept. 6-11)
202-872-6293
American Chemical Society
Cilantro, that favorite salsa ingredient, purifies drinking water
INDIANAPOLIS, Sept. 12, 2013 — Hints that a favorite ingredient in Mexican, Southeast Asian and other spicy cuisine may be an inexpensive new way of purifying drinking water are on the menu today at the 246th National Meeting & Exposition of the American ...
Alzheimer's patients show striking individual differences in molecular basis of disease
2013-09-12
Alzheimer's disease is thought to be caused by the buildup of abnormal, thread-like protein deposits in the brain, but little is known about the molecular structures of these so-called beta-amyloid fibrils. A study published by Cell Press September 12th in the journal Cell has revealed that distinct molecular structures of beta-amyloid fibrils may predominate in the brains of Alzheimer's patients with different clinical histories and degrees of brain damage. The findings pave the way for new patient-specific strategies to improve diagnosis and treatment of this common and ...
Darwin's dilemma resolved: Evolution's 'big bang' explained by 5x faster rates
2013-09-12
The incredible burst of innovation in animals' body plans and habits during the Cambrian explosion, between 540 and 520 million years ago, can be explained by a reasonable uptick in evolutionary rates. The discovery, based on the first rigorous estimates of early evolutionary rates in arthropods, shows that evolution's "big bang" is compatible with natural selection as Darwin envisioned it, say researchers reporting their findings in Current Biology, a Cell Press publication, on September 12.
"This simultaneous burst of life, with few or no precursors, had seemed at ...
Study sheds light on genetics of how and why fish swim in schools
2013-09-12
SEATTLE – How and why fish swim in schools has long fascinated biologists looking for clues to understand the complexities of social behavior. A new study by a team of researchers at Fred Hutchinson Cancer Research Center may help provide some insight.
To be published online in the Sept. 12 issue of Current Biology, the study found that two key components of schooling – the tendency to school and how well fish do it – map to different genomic regions in the threespine stickleback, a small fish native to the Northern Hemisphere.
That's important, said lead author Anna ...
Autism gene stunts neurons, but growth can be restored, in mice
2013-09-12
PROVIDENCE, R.I. [Brown University] — Brown University researchers have traced a genetic deficiency implicated in autism in humans to specific molecular and cellular consequences that cause clear deficits in mice in how well neurons can grow the intricate branches that allow them to connect to brain circuits. The researchers also show in their study (online Sep. 12, 2013, in Neuron) that they could restore proper neuronal growth by compensating for the errant molecular mechanisms they identified.
The study involves the gene that produces a protein called NHE6. Mutation ...
New info on an elusive green cicada
2013-09-12
For nearly 80 years, the North American cicada Okanagana viridis has received little attention in scientific literature, but a new article in the Annals of the Entomological Society of America provides the first notes on the song and ecology of this elusive species, and updates its known range.
O. viridis is unusual in a large genus of 60 otherwise arid- or cold-adapted, mostly western U.S. species, in that it is found in the temperate deciduous southern forests of Arkansas, Louisiana, Mississippi, Tennessee, and Texas. It is almost solid bright green, and it calls from ...
La Jolla Institute scientist identifies helper cells that trigger potent responses to HIV
2013-09-12
SAN DIEGO – (September 12, 2013) A major new finding that will significantly advance efforts to create the world's first antibody-based AIDS vaccine was published today by researchers from the La Jolla Institute for Allergy and Immunology.
La Jolla Institute scientist Shane Crotty, Ph.D., a respected vaccine researcher and member of one of the nation's top AIDS vaccine consortiums, showed that certain helper T cells are important for triggering a strong antibody response against HIV, the virus that causes AIDS. Helper T cells are disease-fighting immune cells key in ...